|Bid||120.60 x 0|
|Ask||120.60 x 0|
|Day's range||118.70 - 123.90|
|52-week range||97.00 - 171.65|
|Beta (5Y monthly)||0.35|
|PE ratio (TTM)||12.40|
|Earnings date||25 Feb 2021|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||14 May 2020|
|1y target est||106.42|
The company said its agreement would lapse as it returned to the direct control and management of the Ministry of Defence from 30 June next year.
Britain's defence ministry will take back direct control of the operation and development of the country's nuclear weapons from a consortium of Lockheed Martin <LMT.N>, Serco <SRP.L> and Jacobs Engineering <J.N> in June 2021, it said on Monday. Operation of the Atomic Weapons Establishment, which maintains the warheads for the Trident submarine-based nuclear deterrent, was awarded to the AWE Management consortium in 1999 under a 25-year contract. Lockheed Martin owns 51% and Serco and Jacobs Engineering own 24.5% each of the consortium.
The company's shares rose 17% in early trading after Serco said it now expects annual revenue of around 3.9 billion pounds and underlying trading profit in the range of 160 million pounds to 165 million pounds. A focus on public sector services has sheltered Serco from the impact of the health crisis. The company said performance in all regions was better than it expected, and that it was awarded more work related to COVID-19 test and trace services for Britain's National Health Service and immigration services in Australia.